Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial

Maurie Markman, Pan Liu, Sharon P. Wilczynski et al. · Journal of Clinical Oncology · 2003 · 458 citations

Medicine, Oncology, Pharmacotherapy +13

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers

Steven J. Skates, Fengji Xu, Yinhua Yu et al. · Cancer · 1995 · 230 citations · Full text

Medicine, Gynecology, Oncology +16

Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels

Gordon Rustin, Maria Marples, Ann E. Nelstrop et al. · Journal of Clinical Oncology · 2001 · 203 citations

Medicine, Gynecology, Oncology +17

Role of tumour markers in monitoring epithelial ovarian cancer.

UCL Discovery (University College London) · 2000 · 109 citations

Medicine, Gynecology, Oncology +16